Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05651711 |
|---|---|
| Brief Title: | A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon) (ROCKET-Horizon) |
| First Submitted : | December 7, 2022 |
| First Submitted that Met QC Criteria : | December 7, 2022 |
| First Posted : | December 15, 2022 |
| Last Update Submitted that Met QC Criteria : | January 5, 2024 |
| Last Update Posted : | January 8, 2024 |